Will AI lead to a quicker diagnosis of diabetes, a condition often called the silent killer? IBM researchers are hoping so. They recently announced an AI-powered screening tool that could potentially identify Type 1 diabetesantibodies in people’s blood.
At the American Diabetes Association’s 79th Scientific Sessions in early June, IBM and JDRF (formerly known as the Juvenile Diabetes Research Foundation), a nonprofit that spearheads Type 1 diabetes research, unveiled a predictive AI tool that has mapped the presence of Type 1 diabetes antibodies in blood to figure out exactly when and how the condition could develop. Jianying Hu, IBM fellow and global science leader of AI for health care at IBM Research, told Engadget that the AI was fed data from more than 22,000 people from the United States, Sweden and Finland.
Read the entire article HERE